King Star Capital
Signal active
Investment Firm
Overview
King Star Capital is a U.S. dollar fund managed by Kington Capital. The first phase of the fund focuses on innovative biopharmaceutical companies in China. It has invested in leading anti-tumor biopharmaceutical R&D enterprises including CStone Pharmaceuticals, MabSpace Biosciences, JW Therapeutics and Adagene Pharmaceutical.
Highlights
Founded
2017
Industry
Venture Capital
Employees
0
Investment
6
Lead Investment
0
Exits
4
Stages
Early Stage Venture, Late Stage Venture
Investor Type
Venture Capital
Location
Asia
Contact Information
Social
N/A
Profile Resume
King Star Capital, established in 2017 and headquartered in Asia., specializes in Early Stage Venture, Late Stage Venture investments across Health Care, Medical Device, Robotics, Financial Services, Venture Capital, Finance, Funding Platform, Biotechnology, Medical, Asset Management. The organization boasts a portfolio of 5 investments, with an average round size of $96.1M and 4 successful exits. Their recent investments include Ronovo Surgical, INCE Capital, LongRiver Investments, Gracell Biotechnologies, Vivo Capital. The highest investment round they participated in was $58.0B. Among their most notable exits are Ronovo Surgical and INCE Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
King Star Capital has made 6 investments. Their most recent investment was on Jun 14, 2024, when Ronovo Surgical raised $41.3M.
investments
6
Diversity investments
0
Lead investments
0
Number of exits
4
Investments
6
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| May 11, 2018 | MabSpace Biosciences | Biotechnology | 40.0M |
| Feb 25, 2019 | Gracell Biotechnologies | Biotechnology | 85.0M |
| Oct 28, 2020 | Gracell Biotechnologies | Biotechnology | 100.0M |
| Jun 14, 2024 | Ronovo Surgical | Health Care | 41.3M |
Exits
4
Funding Timeline
Funding rounds
6
Investors
0
Funds
0
Funding Rounds
6
King Star Capital has raised 6 rounds. Their latest funding was raised on Jun 14, 2024 from a Series B - Ronovo Surgical round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| May 11, 2018 | Series B - MabSpace Biosciences | - | 40.0M | - |
| Feb 25, 2019 | Series B - Gracell Biotechnologies | - | 85.0M | - |
| Oct 28, 2020 | Series C - Gracell Biotechnologies | - | 100.0M | - |
| Jun 14, 2024 | Series B - Ronovo Surgical | - | 41.3M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.